Vera Therapeutics (VERA) Debt Ratio (2021 - 2026)

Vera Therapeutics (VERA) has 6 years of Debt Ratio data on file, last reported at 0.12 in Q1 2026.

• Quarterly Debt Ratio rose 47.27% year-over-year to 0.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.12 (up 47.27% YoY) and the FY2025 annual result came in at 0.1, up 33.57% from the prior year.
• Debt Ratio improved to 0.12 in Q1 2026, from 0.1 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.28 in Q4 2023 to a low of 0.04 in Q1 2022.
• A 5-year average of 0.12 and a median of 0.13 in 2024 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio surged 316.8% — and 2024, when it sank 73.16%.
• Tracing VERA's Debt Ratio over 5 years: stood at 0.21 in 2022, then soared by 34.43% to 0.28 in 2023, then slumped by 73.16% to 0.08 in 2024, then jumped by 33.57% to 0.1 in 2025, then advanced by 18.48% to 0.12 in 2026.
• The last three Debt Ratio figures came in at 0.12 (Q1 2026), 0.1 (Q4 2025), and 0.14 (Q3 2025), per Business Quant data.